Scientists have developed the world’s first drug, muvalaplin, to treat high levels of lipoprotein(a). Lipoprotein(a) is a type of “bad cholesterol” and elevated blood levels are linked to increased risk of heart attacks and strokes.1,2 It is controlled by genetics and does not respond to treatment, diet, or lifestyle changes. Twenty percent of the world’s population […]
The post New Drug Drops Bad Cholesterol by 65% appeared first on Medical News Bulletin.
Scientists have developed the world’s first drug, muvalaplin, to treat high levels of lipoprotein(a). Lipoprotein(a) is a type of “bad cholesterol” and elevated blood levels are linked to increased risk of heart attacks and strokes.1,2 It is controlled by genetics and does not respond to treatment, diet, or lifestyle changes. Twenty percent of the world’s population […]
The post New Drug Drops Bad Cholesterol by 65% appeared first on Medical News Bulletin.
